It is possible to determine how quickly the disease might advance by detecting immune cells in the cerebrospinal fluid after diagnosing ALS, according to researchers.
The body's strength fluctuates as the seasons change. A robust immune system will shield you from disease-causing pathogens and lower your risk of experiencing severe illnesses. To adapt to the outside environment and temperature, each season necessitates a different routine and nutrition.
A Monash University study exploring the emerging gut-skin axis has found that microbial fermentation of dietary fibre in the gut can protect against allergic skin disease. The research could potentially lead to novel treatments to prevent or treat allergies.
New Delhi [India], November 26 (ANI/SRV) : Founded in 2021 by Dr Tarun Bharti, Tick My Health has grabbed the award for Most Innovative Nutritionist Clinic in Delhi NCR.
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine C
A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma in preclinical tests, according to a study from Weill Cornell M
The study found protein is crucial in helping malignancies avoid immune attacks. The "fragile X mental retardation protein" (FMRP) is a protein that controls a network of genes and cells in the tumor microenvironment that help the tumor "hidden" from immune cells.
A Ludwig Cancer Research study has revealed a single protein expressed at high levels by cancer cells across a broad range of malignancies that erects a multifaceted barrier to anti-cancer immune responses in mouse models of cancer and so shields tumours from immune detection and destruction
In a new study, researchers from UC San Francisco and Vanderbilt University Medical Center identified particular immune cells that cause lethal cardiac damage in a small subsection of cancer immunotherapy patients.
Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumour cells. Their introduction a decade ago marked a major advance in cancer therapy, but only 10 per cent to 30 per cent of treated patients experience long-term improvement.
Researchers at Duke Health have reported that an immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew.